Published on 1/14/2013 in the Prospect News Emerging Markets Daily.
New Issue: Singapore's Biosensors prices S$300 million 4 7/8% notes due 2017 at par
By Christine Van Dusen
Atlanta, Jan. 14 - Singapore's Biosensors International Group Ltd. priced a S$300 million issue of 4 7/8% notes due 2017 at par to yield 4 7/8%, a market source said.
Credit Suisse (Singapore) Ltd. and Standard Chartered Bank were the bookrunners for the Regulation S deal.
Biosensors International develops, manufactures and markets medical devices for interventional cardiology and critical care procedures.
| Issuer: | Biosensors International Group Ltd.
|
| Amount: | S$300 million
|
| Maturity: | Jan. 23, 2017
|
| Description: | Notes
|
| Bookrunners: | Credit Suisse (Singapore) Ltd., Standard Chartered Bank
|
| Coupon: | 4 7/8%
|
| Price: | Par
|
| Yield: | 4 7/8%
|
| Trade date: | Jan. 14
|
| Settlement date: | Jan. 23
|
| Distribution: | Regulation S
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
